12,484 Shares in CorVel Corp. (NASDAQ:CRVL) Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. bought a new position in shares of CorVel Corp. (NASDAQ:CRVL) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 12,484 shares of the business services provider’s stock, valued at approximately $1,398,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. SG Americas Securities LLC boosted its stake in CorVel by 519.5% during the 1st quarter. SG Americas Securities LLC now owns 9,416 shares of the business services provider’s stock worth $1,054,000 after acquiring an additional 7,896 shares during the last quarter. GAMMA Investing LLC increased its stake in CorVel by 58.6% in the first quarter. GAMMA Investing LLC now owns 685 shares of the business services provider’s stock valued at $77,000 after purchasing an additional 253 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in CorVel by 44.7% in the first quarter. Farther Finance Advisors LLC now owns 816 shares of the business services provider’s stock worth $93,000 after purchasing an additional 252 shares during the period. Impact Capital Partners LLC raised its holdings in CorVel by 8.3% in the first quarter. Impact Capital Partners LLC now owns 7,568 shares of the business services provider’s stock worth $847,000 after purchasing an additional 583 shares during the period. Finally, Chatham Capital Group Inc. grew its holdings in shares of CorVel by 4.4% in the 1st quarter. Chatham Capital Group Inc. now owns 57,955 shares of the business services provider’s stock valued at $6,489,000 after buying an additional 2,440 shares during the period. Institutional investors own 51.36% of the company’s stock.

Analyst Ratings Changes

Separately, Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research note on Friday, April 18th.

Insider Transactions at CorVel

In other news, Director R Judd Jessup sold 687 shares of the company’s stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $111.25, for a total transaction of $76,428.75. Following the completion of the transaction, the director now directly owns 128,832 shares of the company’s stock, valued at $14,332,560. This represents a 0.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alan Hoops sold 3,000 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $113.05, for a total value of $339,150.00. Following the transaction, the director now owns 16,688 shares of the company’s stock, valued at approximately $1,886,578.40. The trade was a 15.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 29,602 shares of company stock valued at $3,379,049 over the last quarter. Corporate insiders own 47.57% of the company’s stock.

CorVel Price Performance

NASDAQ CRVL opened at $102.67 on Wednesday. CorVel Corp. has a one year low of $81.46 and a one year high of $128.61. The firm has a market cap of $5.27 billion, a P/E ratio of 55.90 and a beta of 1.02. The stock’s 50-day moving average is $111.44 and its 200-day moving average is $115.46.

CorVel (NASDAQ:CRVL) last posted its earnings results on Thursday, May 22nd. The business services provider reported $0.51 earnings per share (EPS) for the quarter. CorVel had a return on equity of 32.55% and a net margin of 10.63%. The business had revenue of $231.51 million during the quarter.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.